Dulaglutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options

Introduction

Trulicity® is Eli Lilly’s brand name for dulaglutide, the weekly GLP-1 receptor agonist approved for type 2 diabetes and cardiovascular risk reduction. List prices have climbed steadily since the 2014 launch. In 2026, Trulicity sits among the more expensive long-acting GLP-1 options, partly because Lilly is prioritizing its newer drugs Mounjaro® and Zepbound® (tirzepatide) and partly because there’s no generic competition yet.

Here’s what dulaglutide actually costs in 2026 across different access routes.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the List Price of Trulicity?

Trulicity’s wholesale acquisition cost was 979.86 dollars per month as of early 2026, regardless of dose. That covers four single-use auto-injector pens (one per week). Lilly has raised the WAC modestly each year, typically 3 to 5 percent annually since 2018.

Quick Answer: Trulicity list price is roughly 980 dollars per month for any dose

The interesting feature of Trulicity pricing is that all four available doses (0.75, 1.5, 3, and 4.5 mg) cost the same. This is standard for biologics with weekly dosing. The molecule cost dominates, not the dose strength.

These are list prices, not what most patients pay. Insurance, savings cards, and pharmacy benefit manager rebates change the actual cost dramatically.

Will Insurance Cover Dulaglutide?

For type 2 diabetes, yes, in nearly all commercial and Medicare Part D plans. Dulaglutide is a standard tier 2 or tier 3 formulary drug under most plan designs. Copays typically range from 25 to 95 dollars per month for commercial plans, and 47 to 100 dollars under Medicare Part D before reaching the catastrophic phase.

Prior authorization is sometimes required, typically asking for HbA1c documentation, prior diabetes medications tried, and clinical justification. Approval rates are high (over 85 percent on first request) because dulaglutide is well-established for type 2 diabetes with strong outcomes data from REWIND.

For weight loss without diabetes, no, insurance generally won’t cover dulaglutide. It’s not FDA-approved for that indication, so off-label prescribing isn’t reimbursed by commercial or Medicare plans.

What About Medicare Coverage in 2026?

Medicare Part D covers dulaglutide for type 2 diabetes. Typical 2026 copays under Part D plans range from 47 to 105 dollars per month after meeting the deductible, depending on plan formulary tier and pharmacy.

The Inflation Reduction Act enabled Medicare to negotiate Part D drug prices. Dulaglutide (Trulicity) was selected for the second wave of negotiations in 2025. The Maximum Fair Price will be 408 dollars per month effective January 2027, a 58 percent reduction from current Part D plan costs.

For 2026 specifically, the original Part D pricing structure remains in effect. Out-of-pocket costs for Medicare beneficiaries on dulaglutide are subject to the 2,000 dollar annual cap that became effective in 2025, so even patients without supplemental coverage hit the limit relatively early in the year.

How Does the Trulicity Savings Card Work?

Eli Lilly offers a Trulicity savings card that brings the copay as low as 25 dollars per month for commercially insured patients. The maximum benefit is 150 dollars per month, with a 12-month enrollment period.

The card excludes federal program beneficiaries (Medicare, Medicaid, TRICARE, VA). The exclusion is mandatory under federal anti-kickback rules. So patients on Medicare can’t use the Trulicity savings card to lower their copay.

For commercially insured patients, the math works out to about 300 dollars per year out of pocket if the copay is fully covered by the card maximum. Pretty manageable for most middle-income households.

Are There Cash-pay Options for Trulicity?

GoodRx and similar coupon services list Trulicity at retail pharmacies in the 920 to 1,050 dollar range cash, basically at list price. Coupons rarely reduce this meaningfully because there’s no generic competition.

Cost Plus Drugs (Mark Cuban’s company) doesn’t currently stock Trulicity because Lilly hasn’t agreed to supply at the Cost Plus model’s pricing requirements. That may change after the Medicare negotiated price takes effect in 2027.

Some Canadian pharmacies sell Trulicity at lower prices (around 350 to 450 dollars per month), but US importation is technically restricted and quality assurance is a concern for some patients. The FDA personal importation policy exists in a gray area.

Is There Generic Dulaglutide?

No FDA-approved generic dulaglutide is available in 2026. The primary patent on the molecule extends to 2027, with secondary patents on the autoinjector device potentially extending through 2030 if successfully defended.

Two ANDA filers (Teva and Sandoz) have submitted abbreviated applications for dulaglutide. The FDA review typically takes 18 to 30 months. Generic launch is possible in 2027 to 2028, depending on patent litigation outcomes.

Biosimilar dulaglutide is also in development by several manufacturers but faces the same patent barriers as small-molecule generics. The IgG4 Fc fragment complicates the biosimilar pathway compared with simpler peptide GLP-1s.

Is There Compounded Dulaglutide?

Rarely. Dulaglutide’s complex molecular structure (60 kDa fusion protein with specific glycosylation) makes it difficult and expensive to compound. Most 503A and 503B pharmacies don’t offer it.

The few compounders who do produce dulaglutide typically charge 250 to 400 dollars per month and may not match the brand product’s pharmacokinetic profile. The clinical equivalence of compounded dulaglutide is not established.

For patients who can’t access brand Trulicity due to cost, switching to compounded semaglutide is more common because semaglutide is technically simpler to compound. TrimRx works with FDA-registered compounding pharmacies for semaglutide and tirzepatide rather than dulaglutide.

How Does Trulicity Cost Compare with Alternatives?

Monthly list prices in 2026 for common GLP-1s:

• Trulicity (dulaglutide): 980 dollars
• Ozempic® (semaglutide for diabetes): 968 dollars
• Wegovy® (semaglutide for obesity): 1,349 dollars
• Mounjaro (tirzepatide for diabetes): 1,069 dollars
• Zepbound (tirzepatide for obesity): 1,086 dollars
• Victoza® (liraglutide for diabetes): 1,055 dollars
• Saxenda® (liraglutide for obesity): 1,349 dollars

Dulaglutide and semaglutide for diabetes are in roughly the same price band. Tirzepatide and the obesity-labeled drugs are pricier.

For type 2 diabetes coverage decisions, the price differences are usually small. Insurance formulary placement matters more than list price for what you actually pay.

Key Takeaway: Commercial savings card brings copay as low as 25 dollars per month

What Happens After Medicare Negotiated Pricing in 2027?

The Maximum Fair Price for dulaglutide effective January 2027 is 408 dollars per month. Medicare Part D plans must offer this price to enrolled beneficiaries. Commercial plans aren’t directly affected, but the negotiated price often pulls down list prices over time.

Several scenarios could play out:

1. Lilly maintains current commercial WAC and accepts the Medicare cut
2. Lilly reduces commercial WAC to align with the negotiated price
3. Lilly accelerates a price cut to encourage formulary preference
4. Lilly transitions patients to newer agents (Mounjaro) to preserve revenue

The most likely outcome is scenario 1 in the short term, with gradual commercial price erosion over 2 to 3 years as biosimilar dulaglutide approaches market entry.

Patient Assistance Programs for Dulaglutide

Lilly’s Patient Assistance Program (LillyCares) provides free Trulicity to eligible patients without insurance who meet income criteria, typically 400 percent of the federal poverty level or below.

The application process requires income documentation, prescriber attestation, and proof of US residency. Approval typically takes 4 to 6 weeks. Once approved, free medication is shipped directly to the patient or prescriber for up to 12 months.

For lower-income Medicare beneficiaries, the Extra Help program (also called Low Income Subsidy or LIS) reduces Part D copays to under 5 dollars per month. Eligibility is based on income and assets. Applications go through Social Security or state Medicaid offices.

What Annual Cost Can I Expect for Dulaglutide?

Annual cost scenarios for typical 2026 patients:

Commercially insured with Lilly savings card: 25 to 150 dollars per month, total annual cost approximately 300 to 1,800 dollars after card maximum.

Medicare Part D: typical copay 47 to 105 dollars per month, with the 2,000 dollar annual cap providing protection. Total out-of-pocket approximately 800 to 2,000 dollars per year.

Uninsured with LillyCares program (if eligible by income): zero dollars for medication after application approval.

Uninsured paying cash without assistance: approximately 11,700 dollars per year at list price. This is rare because most uninsured patients qualify for LillyCares or use one of the savings programs.

For TrimRx patients seeking weight management, our medical team prescribes semaglutide and tirzepatide with different pricing structures. For type 2 diabetes patients managed by primary care or endocrinology with dulaglutide, the cost breakdown above applies.

How Does Dulaglutide Cost Compare with Lifestyle Interventions?

Dulaglutide is expensive compared with non-pharmacologic diabetes interventions, but produces stronger HbA1c reduction than lifestyle changes alone.

Intensive lifestyle programs (DPP-style) typically cost 800 to 1,500 dollars for a 6-month course, often covered by insurance for prediabetes prevention. The DPP showed 58 percent reduction in progression to type 2 diabetes over 3 years.

Bariatric surgery has high upfront cost (15,000 to 30,000 dollars) but is often covered by insurance for severe obesity. Long-term cost effectiveness is favorable due to substantial and durable weight loss.

For patients meeting criteria for both medication and surgery, the choice depends on personal preference, surgical risk, and goals. Dulaglutide is less effective for weight loss but easier to start and discontinue than surgery.

What Financial Assistance Is Available?

Multiple programs help with dulaglutide costs:

1. Lilly Savings Card: commercially insured patients, copay as low as 25 dollars
2. LillyCares Patient Assistance Program: free medication for uninsured patients meeting income criteria (typically 400 percent FPL or below)
3. Medicare Extra Help / Low Income Subsidy: reduces Part D copays to under 5 dollars for eligible beneficiaries
4. State pharmaceutical assistance programs: vary by state, supplement Medicare in some cases
5. Disease-specific foundations: PAN Foundation and others provide grants for diabetes medications

Applications for these programs typically take 2 to 6 weeks. Apply early to avoid treatment gaps. The pharmacy team at your prescriber’s office can often help with the paperwork.

What If I Lose Insurance Coverage Mid-treatment?

Job loss, plan changes, or aging into Medicare can disrupt dulaglutide coverage. Options if you lose commercial insurance:

1. COBRA continuation if eligible (typically expensive but maintains coverage)
2. ACA marketplace plans with dulaglutide coverage
3. LillyCares free medication program for uninsured patients meeting income criteria
4. Switch to generic liraglutide (cheaper alternative if appropriate clinically)
5. Discuss with your prescriber about pausing therapy if affordable alternatives aren’t available

Avoid abruptly stopping dulaglutide without medical guidance. The metabolic and cardiovascular benefits gradually fade after discontinuation. For patients with type 2 diabetes, alternative diabetes medications need to be in place before stopping.

Bottom line: Compounded dulaglutide is rare due to molecular complexity

FAQ

Can I Appeal a Trulicity Prior Authorization Denial?

Yes. Standard appeals include letter of medical necessity with HbA1c values, prior diabetes medications attempted, and clinical justification. Approval on appeal is common when documentation is strong.

Does TrimRx Prescribe Dulaglutide?

TrimRx’s medical team focuses on semaglutide and tirzepatide for weight loss management. We don’t prescribe dulaglutide because it’s not optimal for weight loss outcomes. For type 2 diabetes management with dulaglutide, consult your primary care or endocrinology provider.

Is the Savings Card Valid for Refills?

Yes, within the 12-month enrollment period. Re-enrollment is required each year if you continue using the card. Some patients miss the renewal and pay full copay for a month before re-enrolling.

Can I Get Trulicity From International Pharmacies?

Personal importation from licensed Canadian or other international pharmacies is technically restricted under US law but enforced sporadically for personal-use quantities. Quality and consistency vary. Most US clinicians don’t recommend this route.

Will Biosimilar Dulaglutide Be Cheaper?

Yes, when it launches. Biosimilars typically price 30 to 50 percent below the originator. For dulaglutide, that could mean a monthly cost of 500 to 700 dollars at brand-equivalent insurance tiers. Launch timing is 2027 or later.

What’s the Cheapest Way to Get Dulaglutide Right Now?

For commercially insured patients, the Lilly savings card with copay assistance gets you to roughly 25 to 50 dollars per month. For uninsured patients meeting income criteria, the LillyCares free medication program. For Medicare beneficiaries, the new 2,000 dollar annual out-of-pocket cap.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.